Novocure Reports Positive Phase 2 PANOVA-4 Trial Results for Metastatic Pancreatic Cancer Treatment

Novocure announces positive topline results from the Phase 2 PANOVA-4 trial of Tumor Treating Fields (TTFields) therapy for metastatic pancreatic cancer. The trial met its primary endpoint, achieving a statistically significant improvement in disease control rate compared to historical controls. The TTFields therapy was well-tolerated and plans to present additional results at a future scientific forum.